openPR Logo
Press release

Drug Delivery Market 2018 | Johnson, Bayer

Report Summary

The Global Drug Delivery Market Size is primarily driven by the increasing demand for technological advanced products that are used for drug delivery, and increased number of chronic diseases in the increasing number of geriatric population.

Drug delivery is referred as drug administration in the human body through injections or various other devices. Drug delivery devices are used to inject the therapeutic substances in the body with the help of various routes. These routes of administration depend on the type of disease that a patient suffers, and nature of the drug that is available. Drugs help in improving and extending once life by properly diagnosing the disease. Recently, drug delivery includes the targeted delivery which specially focuses on the target area of the body. In order to achieve efficiency, the targeted drugs act effectively work without creating any side effects to other body parts.

Request for sample copy of this report @
https://www.polarismarketresearch.com/industry-analysis/global-drug-delivery-market/request-for-free-sample

Drug delivery devices also play an important role as they are conventional and implantable. The devices not only help the efficiency but also enhance the accuracy for drug delivery. For instance, the device can help in accurately administrating the drugs like insulin, the devices used are infusion catheters namely valves, set, needles, cannulas and many more. Transcellular and paracellular are most commonly used routes for drug administration. The practice for drug delivery has changed in past few decades that is creating a good pace for the new and existing manufacturers in the near future.

Rising number of technologically advanced products that are used for drug delivery and rising number of chronic diseases globally to boost the drug delivery market.
The drug delivery market is basically driven by the rising prevalence of chronic disease, and increased number of clinical trials that focus on the biologics drugs in the market. Similarly, the rising technological advancements and continuous new product development would also influence the market growth. Moreover, increased government focus on improving the efficiency and safety of drugs will drive the market significantly in the coming years.

Browse Complete Summary of this report @ https://www.polarismarketresearch.com/industry-analysis/global-drug-delivery-market/

Global Drug Delivery Market Taxonomy
The global drug delivery market size is segmented on the basis of route of administration, product, end use and geography.
On the basis of route of administration, the global drug delivery market size is segmented as:
• Oral Drug Delivery
• Skin Drug Delivery
• Ophthalmic Drug Delivery
• Rectal Drug Delivery
• Vaginal Drug Delivery
• Nasal Drug Delivery

On the basis of product development, the global drug delivery market share is segmented as:
• Device
• Transdermal Gel
• Transdermal Patches
• Formulation
• Solid Topical Formulation
• Liquid Topical Formulation
• Semi-Solid Topical Formulation

On the basis of end use, the global drug delivery market size is segmented as:
• Hospitals
• Private Clinics
• Home Care Setting
• Pharmacy Store
• Others

About us Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

Contact us-
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Market 2018 | Johnson, Bayer here

News-ID: 1351456 • Views:

More Releases from Polaris Market Research & Consulting

Cooling Fabrics Market Is Expected to Reach US$ 4.66 Billion by 2032, at a CAGR of 7.70% | Polaris Market Research
Cooling Fabrics Market Is Expected to Reach US$ 4.66 Billion by 2032, at a CAGR …
𝑻𝒉𝒆 𝒈𝒍𝒐𝒃𝒂𝒍 𝑪𝒐𝒐𝒍𝒊𝒏𝒈 𝑭𝒂𝒃𝒓𝒊𝒄𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 𝒘𝒂𝒔 𝒆𝒔𝒕𝒆𝒆𝒎𝒆𝒅 𝒂𝒕 𝑼𝑺𝑫 2.42 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒊𝒏 2023. 𝑳𝒐𝒐𝒌𝒊𝒏𝒈 𝒇𝒐𝒓𝒘𝒂𝒓𝒅, 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕 𝒊𝒔 𝒂𝒏𝒕𝒊𝒄𝒊𝒑𝒂𝒕𝒆𝒅 𝒕𝒐 𝒈𝒓𝒐𝒘 𝒕𝒐 𝑼𝑺𝑫 4.66 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒃𝒚 2032, 𝒆𝒙𝒉𝒊𝒃𝒊𝒕𝒊𝒏𝒈 𝒂 𝒄𝒐𝒎𝒑𝒐𝒖𝒏𝒅 𝒂𝒏𝒏𝒖𝒂𝒍 𝒈𝒓𝒐𝒘𝒕𝒉 𝒓𝒂𝒕𝒆 (𝑪𝑨𝑮𝑹) 𝒐𝒇 7.70% 𝒐𝒗𝒆𝒓 𝒕𝒉𝒆 𝒇𝒐𝒓𝒆𝒄𝒂𝒔𝒕 𝒑𝒆𝒓𝒊𝒐𝒅 𝒇𝒓𝒐𝒎 2024 𝒕𝒐 2032. 𝑻𝒉𝒆 𝒎𝒂𝒊𝒏 𝒇𝒂𝒄𝒕𝒐𝒓𝒔 𝒅𝒓𝒊𝒗𝒊𝒏𝒈 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕 𝒈𝒓𝒐𝒘𝒕𝒉 𝒂𝒓𝒆 𝒓𝒊𝒔𝒊𝒏𝒈 𝒅𝒊𝒔𝒑𝒐𝒔𝒂𝒃𝒍𝒆 𝒊𝒏𝒄𝒐𝒎𝒆 𝒂𝒏𝒅 𝒑𝒆𝒓 𝒄𝒂𝒑𝒊𝒕𝒂 𝒔𝒑𝒆𝒏𝒅𝒊𝒏𝒈, 𝒂𝒔 𝒘𝒆𝒍𝒍 𝒂𝒔 𝒂 𝒓𝒊𝒔𝒆 𝒊𝒏 𝒕𝒉𝒆 𝒅𝒆𝒎𝒂𝒏𝒅 𝒇𝒐𝒓 𝒔𝒑𝒐𝒓𝒕𝒔 𝒂𝒏𝒅
Connected Medical Devices Market is projected to grow to US$ 190.63 Billion by 2032 |according to a new study by Polaris Market Research
Connected Medical Devices Market is projected to grow to US$ 190.63 Billion by 2 …
The global Connected Medical Devices Market was valued at USD 49.57 billion in 2022. Looking forward, the market is projected to grow to USD 190.63 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.4% over the forecast period from 2023 to 2032. The rising aging population and the expansion of telehealth services are the primary factors propelling the market forward. Besides, the growing prevalence of chronic diseases
Surgical Blade Market is expected to reach US$ 228.57 Million by 2032 | Data by Polaris Market Research
Surgical Blade Market is expected to reach US$ 228.57 Million by 2032 | Data by …
According to a new market research report published by Polaris Market Research, the global Surgical Blade Market is expected to grow at a CAGR of 5.0% from 2023 to 2032. Its examination of technological progressions and developments in the industry and their influence on market attendance is anticipated to drive market expansion. The global market was valued at USD 140.59 million in 2022 to USD 228.57 million by 2032, disclosing
Fructooligosaccharides Market to Grow at CAGR of 8.50% Reaching USD 5.71 Billion By 2032
Fructooligosaccharides Market to Grow at CAGR of 8.50% Reaching USD 5.71 Billion …
𝐅𝐫𝐮𝐜𝐭𝐨𝐨𝐥𝐢𝐠𝐨𝐬𝐚𝐜𝐜𝐡𝐚𝐫𝐢𝐝𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 Continuing research into the health benefits of FOS and inventive commodity advancement has the possibility of capitulating new FOS-dependent commodities with improved functionality, which is pushing the market growth. Our thorough analysis of the Fructooligosaccharides Market covers the industry size, share, recent developments, and top trends. Besides, we have in-depth examined all the major regions and segments. 𝐓𝐡𝐞 𝐅𝐫𝐮𝐜𝐭𝐨𝐨𝐥𝐢𝐠𝐨𝐬𝐚𝐜𝐜𝐡𝐚𝐫𝐢𝐝𝐞𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 • Market Size: The global market for fructooligosaccharides was valued

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug